These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 8262836)
1. In vivo radiosensitization efficacy of KU-2285 and etanidazole at clinically relevant low radiation doses. Oya N; Shibamoto Y; Sasai K; Sugiyama T; Abe M Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1113-9. PubMed ID: 8262836 [TBL] [Abstract][Full Text] [Related]
2. Combined cytokinesis-block micronucleus and chromosomal aberration assay for the evaluation of radiosensitizers at low radiation doses. Oya N; Shibamoto Y; Shibata T; Sasai K; Sugiyama T; Abe M Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1153-9. PubMed ID: 7961025 [TBL] [Abstract][Full Text] [Related]
3. Radiosensitization efficacy of KU-2285, RP-170 and etanidazole at low radiation doses: assessment by in vitro cytokinesis-block micronucleus assay. Shibamoto Y; Streffer C; Sasai K; Oya N; Abe M Int J Radiat Biol; 1992 Apr; 61(4):473-8. PubMed ID: 1349329 [TBL] [Abstract][Full Text] [Related]
4. Comparison of radiosensitizing effect of KU-2285 and SR-2508 at low drug concentrations and doses. Shibata T; Shibamoto Y; Oya N; Sasai K; Murata R; Ishigaki T; Abe M Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):587-90. PubMed ID: 8005820 [TBL] [Abstract][Full Text] [Related]
5. Radiosensitization by a new potent nucleoside analog: 1-(1',3',4'-trihydroxy-2'-butoxy)methyl-2-nitroimidazole(RP-343). Murayama C; Suzuki A; Sato C; Tanabe Y; Shoji T; Miyata Y; Nishio A; Suzuki T; Sakaguchi M; Mori T Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):433-43. PubMed ID: 8514541 [TBL] [Abstract][Full Text] [Related]
6. Optical isomers of a new 2-nitroimidazole nucleoside analog (PR-350 series): radiosensitization efficiency and toxicity. Oya N; Shibamoto Y; Sasai K; Shibata T; Murata R; Takagi T; Iwai H; Suzuki T; Abe M Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):119-27. PubMed ID: 7642409 [TBL] [Abstract][Full Text] [Related]
7. KIN-804 vs. KU-2285 as a radiosensitizer for clinical use. Oya N; Shibamoto Y; Shibata T; Murata R; Iwai H; Sugiyama T; Abe M Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):595-600. PubMed ID: 8005822 [TBL] [Abstract][Full Text] [Related]
8. A fluorinated 2-nitroimidazole, KU-2285, as a new hypoxic cell radiosensitizer. Sasai K; Nishimoto S; Shimokawa K; Hisanaga Y; Kitakabu Y; Shibamoto Y; Zhou L; Wang J; Takahashi M; Kagiya T Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1249-54. PubMed ID: 1828462 [TBL] [Abstract][Full Text] [Related]
9. Radiosensitizing activity and pharmacokinetics of multiple dose administered KU-2285 in peripheral nerve tissue in mice. Iwai H; Matsuno E; Sasai K; Shibamoto Y; Abe M Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):591-4. PubMed ID: 8005821 [TBL] [Abstract][Full Text] [Related]
10. A comparison of radiosensitization by etanidazole and pimonidazole in mouse tumors. Stone HB; Hirst VK; Cribbs R; Luu YH; Brown JM Int J Radiat Oncol Biol Phys; 1991 May; 20(5):987-95. PubMed ID: 1827089 [TBL] [Abstract][Full Text] [Related]
11. In vivo radiosensitizing activity of a new fluorinated hypoxic cell radiosensitizer, KU-2285, in combination with radiation dose fractionation. Sasai K; Fushiki M; Yukawa Y; Suyama S; Iwai H; Shibamoto Y; Nishimoto S; Takahashi M; Abe M Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1231-4. PubMed ID: 1938521 [TBL] [Abstract][Full Text] [Related]
12. The effect of glutathione (GSH) depletion in vivo by buthionine sulfoximine (BSO) on the radiosensitization of SR 2508. Kramer RA; Soble M; Howes AE; Montoya VP Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1325-9. PubMed ID: 2523885 [TBL] [Abstract][Full Text] [Related]
13. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors. Ono K; Takahashi M; Nishidai T; Dodo Y; Shibamoto Y; Hiraoka M; Yukawa Y; Abe M Radiat Med; 1984; 2(1):71-5. PubMed ID: 6242712 [TBL] [Abstract][Full Text] [Related]
14. Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170). Murayama C; Suzuki A; Suzuki T; Miyata Y; Sakaguchi M; Tanabe Y; Tanaka N; Mori T Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):575-81. PubMed ID: 2528527 [TBL] [Abstract][Full Text] [Related]
15. Radiosensitization of hypoxic cells in vivo by SR 2508 at low radiation doses: a preliminary report. Brown JM; Yu NY Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1207-12. PubMed ID: 6236184 [TBL] [Abstract][Full Text] [Related]
16. Radiosensitization by 2-nitroimidazole nucleoside analog RP-170: radiosensitizing effects under both intravenous and oral administration. Murayama C; Suzuki A; Sato C; Tanabe Y; Miyata Y; Shoji T; Suzuki T; Sakaguchi M; Mori T Int J Radiat Oncol Biol Phys; 1992; 22(3):557-60. PubMed ID: 1531214 [TBL] [Abstract][Full Text] [Related]
18. Testing of new hypoxic cell sensitizers in vivo. Stone HB; Sinesi MS Radiat Res; 1982 Jul; 91(1):186-98. PubMed ID: 6212963 [No Abstract] [Full Text] [Related]
19. Tumor radiosensitivity prediction by the cytokinesis-block micronucleus assay. Shibamoto Y; Streffer C; Fuhrmann C; Budach V Radiat Res; 1991 Dec; 128(3):293-300. PubMed ID: 1961926 [TBL] [Abstract][Full Text] [Related]
20. Effect of pH, oxygenation, and temperature on the cytotoxicity and radiosensitization by etanidazole. Teicher BA; Herman TS; Holden SA Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):723-31. PubMed ID: 1825994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]